Plerixafor is a bicyclam compound that acts as a CXCR4 chemokine receptor antagonist. It is primarily recognized for its ability to mobilize hematopoietic stem cells from the bone marrow into the peripheral bloodstream.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 110078-46-1
N2-acetylaciclovir
pharmaceutical raw material
Ascomycin
pharmaceutical raw material
Petrolite E 2020
pharmaceutical raw material
Temocapril hydrochloride
pharmaceutical raw material
1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane
YIQPUIGJQJDJOS-UHFFFAOYSA-N
C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3